Surgical Simulator Systems and Methods
US-2024296754-A1 · Sep 5, 2024 · US
US10699599B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10699599-B2 |
| Application number | US-201816011159-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 18, 2018 |
| Priority date | Mar 20, 2015 |
| Publication date | Jun 30, 2020 |
| Grant date | Jun 30, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A hydrogel liquid precursor includes an inorganic mineral and a monomer, wherein the inorganic mineral accounts for 15 percent by mass or more of the hydrogel liquid precursor, wherein the hydrogel liquid precursor has an initial viscosity of 20 mPa·s or less at 25 degrees C., and wherein the hydrogel liquid precursor has a ratio of a two-week viscosity to the initial viscosity of from 0.90 to 1.10, the two-week viscosity representing a viscosity of the hydrogel liquid precursor at 25 degrees C. after being left at 50 degrees C. for two weeks.
Opening claim text (preview).
What is claimed is: 1. A hydrogel modeling object comprising: an inorganic mineral; a phosphonic acid compound; and a polymer, wherein the inorganic mineral accounts for 15 percent by mass or more of the hydrogel modeling object, and wherein the hydrogel modeling object has an 80 percent compressive stress-strain of 1.0 MPa or more. 2. The hydrogel modeling object according to claim 1 , wherein the inorganic mineral includes a laminate mineral. 3. The hydrogel modeling object according to claim 1 used as an internal organ model. 4. The hydrogel modeling object according to claim 1 , wherein the phosphonic acid compound is represented by the following Chemical formula 1, where R represents a substituted or non-substituted divalent substitution group. 5. The hydrogel modeling object according to claim 4 , wherein R in the Chemical formula 1 includes —(R 1 )C(R 2 )—, where R 1 and R 2 each, independently represent substituted or non-substituted alkyl groups. 6. The hydrogel modeling object according to claim 4 , wherein R in the Chemical formula 1 includes —(OH)C(CH 3 )—. 7. A hydrogel modeling object comprising: a first modeled portion including the hydrogel modeling object of claim 1 ; and a second modeled portion including a second hydrogel modeling object having a different modulus of compressive elasticity from a compressive elasticity of the hydrogel modeling object of claim 1 , wherein the first modeled portion includes the second modeling portion or the second modeled portion includes the first modeled portion.
Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials · CPC title
using individual droplets, e.g. from jetting heads · CPC title
Phosphonic compounds, e.g. R—P(:O)(OR')2 · CPC title
Macromolecular gels · CPC title
Products made by additive manufacturing · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.